KRAS and neoplasm: Moreover, a marked decrease in the expression levels of AR but also of its downstream regulated gene KLK3 was observed, as well as marked downregulation of genes involved in tumor cell biology, such as cell cycle regulators, apoptosis inhibitors (BCL-2), KRAS, and genes involved in the PI3K/AKT/mTOR signaling pathway.